Edwards Lifesciences

Edwards Lifesciences (Nasdaq/NYSE: EW) is a Health Care Equipment company operating within the Health Care sector of the US equity market.

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

The company reports trailing twelve-month revenue of $1.65B and net income of $380.70M.

Key metrics include a return on equity of 3.7%, a debt-to-equity ratio of 0.29.

Use FINOTAUR to track EW's price action, review fundamentals, and stay current with company news — all in one research dashboard.